BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $969,239 | +158.1% | 25,682 | +211.6% | 0.01% | +150.0% |
Q2 2023 | $375,506 | -18.5% | 8,242 | -8.8% | 0.00% | -33.3% |
Q4 2022 | $460,871 | -85.1% | 9,042 | -76.4% | 0.00% | -81.2% |
Q2 2021 | $3,090,000 | -72.0% | 38,382 | -70.7% | 0.02% | -74.2% |
Q1 2021 | $11,051,000 | -32.6% | 131,031 | -35.9% | 0.06% | -36.1% |
Q4 2020 | $16,390,000 | +206.0% | 204,262 | +206.7% | 0.10% | +169.4% |
Q3 2020 | $5,356,000 | -12.6% | 66,606 | -9.1% | 0.04% | -14.3% |
Q4 2019 | $6,127,000 | -66.2% | 73,275 | -70.2% | 0.04% | -58.8% |
Q2 2018 | $18,128,000 | -41.3% | 245,500 | -48.3% | 0.10% | -45.5% |
Q1 2018 | $30,905,000 | +7.8% | 475,175 | +7.2% | 0.19% | +12.0% |
Q4 2017 | $28,660,000 | -7.6% | 443,375 | -10.3% | 0.17% | -10.2% |
Q3 2017 | $31,014,000 | +20.0% | 494,250 | +15.8% | 0.19% | +9.4% |
Q2 2017 | $25,843,000 | -18.3% | 426,875 | -30.0% | 0.17% | -18.3% |
Q1 2017 | $31,618,000 | +51.2% | 609,675 | +29.3% | 0.21% | +45.5% |
Q4 2016 | $20,907,000 | +62.3% | 471,525 | +74.3% | 0.14% | +58.9% |
Q3 2016 | $12,879,000 | +141.5% | 270,575 | +108.5% | 0.09% | +119.5% |
Q1 2016 | $5,332,000 | +33.0% | 129,800 | +23.5% | 0.04% | +20.6% |
Q4 2015 | $4,010,000 | +450.1% | 105,100 | +373.4% | 0.03% | +466.7% |
Q3 2015 | $729,000 | -13.2% | 22,200 | +89.7% | 0.01% | -14.3% |
Q3 2014 | $840,000 | -12.0% | 11,700 | -5.6% | 0.01% | 0.0% |
Q2 2014 | $955,000 | – | 12,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |